FDA removal of restrictions on telemedicine abortions prompts celebration, safety concerns

The Food and Drug Administration (FDA) has lifted restrictions on telemedicine abortions, reigniting debate over the administration of the controversial drug mifepristone.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.